Peptide Atlas · Peptide

Ipamorelin

Ipamorelin is the pentapeptide Aib-His-D-2-Nal-D-Phe-Lys-NH2, described as the first selective growth hormone secretagogue; it releases growth hormone through a GHRP-like receptor with potency and efficacy similar to GHRP-6.

emerging

provisional
PubChem 9831659
2 citations
0 discussions
0 followers

Follow this molecule Ask the Hunter-Gatherer

What the evidence says

six tiers, never blended

emerging — human data exists, and it is thin or contested

every claim resolves to its source

All 2 citations resolve to their original source. · 0 posts naming it, 0 members counted once each.

- emerging
  Claim: Phase 2 randomized trial in postoperative ileus: no significant difference from placebo standing
- resolved
Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.
Beck DE, Sweeney WB, McCarter MD, Ipamorelin 201 Study Group
pmid 25331030
- preclinical
  Claim: Development and pharmacology of ipamorelin standing
- resolved
Ipamorelin, the first selective growth hormone secretagogue.
Raun K, Hansen BS, Johansen NL, Thøgersen H, Madsen K, Ankersen M, Andersen PH
pmid 9849822

A claim's standing is its latest row in an append-only history; a tombstone names the later evidence and the reason. The Graveyard and the Resurrection Yard.

Negative findings

failure is information

Nobody has filed a failure yet. Failures are information; this list is waiting for an honest one.